Enviva Inc.
EVA · NYSE
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Revenue | $312,700 | $320,637 | $301,905 | $269,082 |
| % Growth | -2.5% | 6.2% | 12.2% | – |
| Cost of Goods Sold | $581,978 | $268,221 | $260,143 | $287,889 |
| Gross Profit | -$269,278 | $52,416 | $41,762 | -$18,807 |
| % Margin | -86.1% | 16.3% | 13.8% | -7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $36,656 | $27,582 | $21,987 | $30,954 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $78,162 | $2,190 | $17 | $309 |
| Operating Expenses | $114,818 | $63,987 | $51,952 | $30,954 |
| Operating Income | -$384,096 | -$43,432 | -$26,952 | -$53,390 |
| % Margin | -122.8% | -13.5% | -8.9% | -19.8% |
| Other Income/Exp. Net | -$44,139 | -$41,573 | -$28,813 | -$63,457 |
| Pre-Tax Income | -$428,235 | -$85,005 | -$55,765 | -$116,847 |
| Tax Expense | -$220 | $155 | $11 | $12 |
| Net Income | -$428,056 | -$85,195 | -$55,776 | -$116,859 |
| % Margin | -136.9% | -26.6% | -18.5% | -43.4% |
| EPS | -6.1 | -1.14 | -0.81 | -1.73 |
| % Growth | -435.1% | -40.7% | 53.2% | – |
| EPS Diluted | -6.1 | -1.14 | -0.81 | -1.73 |
| Weighted Avg Shares Out | 70,126 | 74,447 | 68,490 | 67,363 |
| Weighted Avg Shares Out Dil | 70,126 | 74,447 | 68,490 | 67,363 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $45,628 | $43,763 | $28,830 | $63,766 |
| Depreciation & Amortization | $63,820 | $36,405 | $29,965 | $34,674 |
| EBITDA | -$318,787 | -$4,837 | $3,030 | -$18,407 |
| % Margin | -101.9% | -1.5% | 1% | -6.8% |